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Abstract
As a chemotherapeutic agent heavily used since 1969, Doxorubicin’s (Doxo) mission is well known
and carried out, in a variety of cancers. Doxo halts cancerous cell replication and causes
cancerous cells to die through inducing cellular apoptosis. The necessary concentration for this
to happen and the way in which these interactions are carried out at molecular level is still under
debate. We use a dual beam optical tweezers to trap and isolate a single DNA molecule so that
we can explore the binding of Doxo at the single molecule level. Stretching the DNA molecule in
the presence of various concentrations of Doxo allow us to quantify the binding and better
understand this complex interaction. Traditional stretch and release experiments in the presence
of Doxo displayed that Doxo binding was not in equilibrium. To obtain the equilibrium binding
properties, the DNA was stretched and held at a constant force, allowing the drug ample time to
bind to the DNA. The equilibrium extensions of DNA upon binding to various concentrations of
Doxo was obtained at four different constant forces. One dimensional lattice binding model,
McGhee - von Hippel Model, was used obtain the binding affinity at each force and extrapolated
to obtain the binding affinity in the absence of force, Kd (0) = 1087 ± 187 nM. This very first
characterization of Doxo binding to DNA at the single molecule level also yields the extension of
the DNA upon a single intercalation event, ∆𝑥eq = 0.40 ± 0.02 nm. The time scale of in which Doxo
reaches binding equilibrium with DNA and the extension obtained upon single binding event
challenges the well believed notion that Doxo is a simple classical intercalator. Understanding
the binding mechanisms of Doxo to DNA at the single molecule level plays a key role to design
new and improved cancer drugs for the future.
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Introduction
The Red Devil
The Red Devil1, alternatively called Red Death2 are nicknames for anticancer drug, Doxorubicin
(Doxo) due to the horrifically brutal side effects it causes to some of the patients already suffering
from cancer1. Doxo was extracted from a bacterium species named Streptomyces peucetius in
1969 and introduced under the name of Adriyamicin3, one of the first two anthracycline cancer
drugs4. Doxo is typically used on cancer patients experiencing boundless cancer progression, and
in most cases Doxo is directly injected into patient’s veins to treat multiple types of cancers
including lymphoma, leukemia, and breast cancer5 to name only a few. If the dosage is not
absolutely perfect then it can cause the patient to suffer cardiotoxic related side effects, where
it can further escalate into death6.
Since the introduction of Doxo in 1969 it has become one of the most used drugs worldwide as a
treatment for cancers with many trade names Adriyamicin®, and Rubex®. Unfortunately, the
binding mechanism of Doxo at molecular level with the DNA is still not clearly understood.
Understanding this interaction is important because cancer occurs due to the rapid replication of
cells, forming what is called a tumor and this process is controlled by DNA. Through the next few
sections of the introduction I will graze over what exactly cancer is, how it is controlled by DNA,
along with the fundament components of DNA, followed by the way in which Doxo inserts itself
into the picture as a therapeutic agent.
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What Exactly is Cancer?
Cancer. The dreaded word that tears families apart; a word that is ultimately recognized as being
a death sentence. Cancer is not only a problem in the United States but across the world.
Highlighting the United States in particular, as of 2019 it was found that cancer was the second
leading cause of death in the country, second only to heart disease7.
Every living organism is made up by cells and these cells divide and multiply to generate more
cells. This is a crucial part of life as it allows for growth and the replacement of dead cells. Cancer
is defined broadly as a disease caused by an uncontrollable division of cells in some part of the
body.
The question that many ask; “Is it possible for a cure?” In many cases cancer can be a treatable
disease with the key being early detection. There are four possible ways to combat this abnormal
cell growth: (1) doctors surgically remove the mass (2) radiation therapy (3) the body attacks the
cancerous cells naturally (4) chemotherapy or another type of medication8.
The human body is wonderfully adapted to naturally combat antagonistic cells through the use
of the immune system. Some cancerous cells though can evade the immune system and its
ultimate destruction to proliferate further. When the cells multiply in an uncontrollable fashion,
they will begin to clump up to form the well-known term, tumor. A tumor is not only found in the
breasts, but also the lungs, brain, and many other parts on the body.
One may ask: well, why do cells divide and multiply uncontrollably in the first place? Now this
question opens pandoras box. When a cell becomes cancerous it can happen through a variety
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of mechanisms: missing/or altered proteins, DNA replication errors, environmental factors and
so much more9.
One way to stop the constant reproduction of the cancerous cell is to target the DNA, which can
be done using chemotherapeutic agents, such as Doxo. To understand how this is done we must
first discuss DNA and cell reproduction, which will be addressed in the next two subsections.

DNA (The Genetic Alphabet)
Since Darwin proposed the theory of evolution in 1859, DNA and proteins were debated as the
genetic material of cells until 1944 when Oswald Avery proved that indeed DNA was the genetic
material (The interesting history of the back and forth debate during this period is highlighted in
appendix 1).The only fact that was known about DNA structure at that time was that the DNA
was composed of four bases; adenine (A), cytosine (C), guanine (G), thymine (T) whose chemical
structures can be seen in Figure 110.
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N
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NH2

O
NH
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N

N
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NH2
N
H

O

Figure 1: Cartoons representing chemical structures of the four nucleotide bases in DNA.
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Erwin Chargaff in 1951 compared the amount of the four base pairs in samples of DNA from
different organisms. Chargaff would conclude that each organism had the same amount of
adenine (A) as thymine (T) and the same amount of guanine (G) as cytosine (C) in their DNA11.
THE DNA BACKBONE
3’ End

This discovery is vital today and known as Chargaff’s Rules

OH
BASE

which led to the concept of somehow adenine pairs up with

O
O

thymine and guanine with cytosine to form the DNA structure.

O

O-

P
O

It was not until 1953 when Rosalind Franklin and Maurice

BASE
O

Wilkins produced the x-ray crystallography

image12

that James

OO

P

Watson and Francis Crick used to determine that DNA forms a

O-

O5’ End

double helix structure13. In this structure the long chain of DNA
was produced by nucleotides linked together through the

Figure 2: A cartoon representation
of the DNA backbone. The pentose
rings (orange) of the nucleotides are

phosphates; this sugar-phosphate generally referred to as the
“backbone” is shown in Figure 2. The phosphate end is labeled

bonded through covalent bonds to
the phosphate groups (purple). The
bases are represented by the four-

as 5’ end, and sugar end is labeled as 3’ end.

colored bubble.

Combined with Chargaff’s Rule, Watson and Crick discovered that adenine and thymine will pair
through two hydrogen bonds while guanine and cytosine will pair through three to create the
double helix structure. A diagram showing the hydrogen bonding between the two sets of bases
is shown in Figure 3.
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Figure 3: The electronegative atoms nitrogen, and oxygen form the two hydrogen bonds (red broken
lines) between the adenine and thymine bases and the three between guanine and cytosine bases.

The double helix structure of DNA looks like a twisted ladder and is often referred to as double
stranded DNA (dsDNA)12. The DNA gets its strength and shape as the base pairs (steps of the
ladder) stack on top of each other and more pi-pi bonding interactions are created13. These base
pairs (bp) in the DNA structure are formed 0.34 nm apart with 10 bp creating a full rotation of
the double helix. The negatively charged phosphate backbone on each side of the DNA running
antiparallel to each other, which can be observed through the 3’ and 5’ notation. This twisting of
the DNA creates a groove pattern in the DNA with major and minor grooves, which alternates
every 3.4 nm. A detailed representation of this can be viewed in Figure 4.
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The DNA Structure

5’

3’

Major Groove
3.4nm

Minor Groove

0.34nm

5’

Sugar-phosphate
backbone

2nm

Figure 4: Simple illustration of obtaining a double helix structure by twisting a ladder (left). A detailed
representation of the backbone and base pairs of the DNA in 2-dimension (middle). Schematic showing the major
and minor grooves of the double helix and a full rotation of 10 bp rising 3.4 nm (right).

Cell Reproduction and DNA Replication
The human body has roughly 10 trillion cells, each containing DNA that is 2 meters (m) in length.
One maybe asking themselves well how does something that is 2 meters in length fit inside a cell
that is only a micron in thickness, or a tenth of the diameter of a strand of hair?
The negatively charged DNA is wrapped around a positively charged protein called a histone,
which condense in groups of 8 forming what is called nucleosomes14,15. This complex of DNA and
proteins in then referred to as chromatin. Chromatin will then be coiled into a further higher
order structure called the chromosome.
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All living things are composed of cells that are constantly dying and being recreated. This process
is especially important for an organism to undergo growth and development. As I mentioned
earlier, it becomes detrimental when a cell begins to divide uncontrollably though, and this is
when it will typically be deemed cancerous. In order for a cell to function properly it requires the
information that is embedded in the DNA. Therefore, when a cell divides to create two new cells
the DNA has to be copied and replicated. Due to the way in which the DNA is packaged into
chromosomes, it requires special enzymes to help in the unwinding process. Enzymes are a form
of protein that acts as a catalyst to assist in a chemical reaction. There are two primary enzymes
that help with this unwinding process, topoisomerase and helicase. These enzymes along with
many other factors need to be precisely coordinated with one another during the replication of
DNA each time a cell divides.
When the DNA is wrapped as tightly as it is inside the cell, it requires additional proteins to relax
the supercoiling, knots, and tangles of the DNA16. During replication when helicase unwinds the
double stranded DNA (dsDNA) and pulls it apart into two single stranded DNA (ssDNA), tension
builds up in the rest of the unwound dsDNA. This creates supercoils and knots, which makes the
further movement of helicase impossible. Topoisomerase binds to the twisted and knotted
dsDNA region periodically to cut and splice it, so the supercoiling can be relaxed. Without this
relaxing process, the DNA replication would not be possible.
This relaxation allows the helicase to continue the unwinding and separation of the dsDNA. As
the helicase unwinds the dsDNA it will create what is called a replication fork (Figure 5).

Introduction | 14

DNA Polymerase
3’
5’

Helicase

3’

5’

Continuous Extension

Okazaki Fragments

DNA Polymerase

5’

Figure 5: Cartoon depiction of a DNA replication fork where Helicase (gray) proceeds to the left to open
the base pairs of the dsDNA molecule into two ssDNA. DNA polymerase (black ring) that binds to the
bottom ssDNA will move towards right (from 3’ to 5’ direction) on the template strand and continuously
place the complementary bases to form a new dsDNA molecule. But the polymerase that binds to the top
ssDNA cannot move continuously as it must move towards the replication fork. Therefore, it must add
complementary bases in segments that are called Okazaki fragments.

DNA polymerase (a molecular motor) will then bind the newly created ssDNA. The role of the
DNA polymerase is to add the complementary base to the ssDNA creating a new dsDNA. DNA
polymerase can only synthesize new DNA in one direction that is 5’ to 3’ on the template strand.
This makes it easy for the movement along one of the strands where the complementary base
will be added continuously to create the new dsDNA (top strand in Figure 5). But for the other
strand the polymerase will create smaller loop fragments called Okazaki fragments, to add the
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complementary bases17 (bottom strand in Figure 5). This DNA replication process creates two
dsDNA from the parental DNA which is needed as a precursor to cell division.

Fighting Cancer with Small Molecules
The molecules that have mass under 900 Daltons (a unit that is used in Physics and Chemistry to
measure mass) are generally considered as small molecules18. These molecules can interact with
DNA on the molecular level, and in some cases rapidly inhibit the replication of the cell through
binding covalently and noncovalently to the DNA. Covalent binding of molecules to DNA is
irreversible whereas noncovalent is reversible. Doxo falls into the category of noncovalent
interactions, where if given
enough time it will bind to
the DNA, but it should also
come off the DNA as well.
Non-covalent binding falls
into three major categories
(Figure 6)19 intercalation,
single stranded binding,

Intercalation

ssDNA Binding

Groove Binding

Figure 6: Different types of non-covalent interactions of small molecules with
DNA. Intercalation (left) involves the sliding of a flat planer molecule between
the bases of the DNA. ssDNA binding (middle) involves the interaction of the
molecule with the bases when the base pairing is broken. Groove binding (right)

and groove binding.

occurs when the molecule will fit into the major or minor grooves of the DNA.

Recall the ladder analogy of DNA from earlier, intercalation is simply adding a hypothetical board
between the steps of the ladder to add strength to the ladder hopefully preventing breaking.
Intercalators have a particular structure where there is a flat planar section of the molecule (the
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board to go in the steps of the ladder) with a bulky side piece. When an intercalator interacts
with the DNA molecule it has characteristic changes where the DNA will be lengthened and
strengthened. This intercalation method can act as a block to both the topoisomerase and
helicase binding and preventing the replication of the DNA. Intercalators have been used for a
long time as a cancer therapeutic because they act as a roadblock to DNA replication designating
the cell for death.
Threading intercalators are special type of intercalators that have bulky side chains on both sides
of the intercalating flat region similar to a dumbbell. To bind, these threading intercalators must
thread one of their bulky side chains through the DNA bases. This extends the time for the binding
and unbinding process, requiring a structural change in DNA20-22. Doxorubicin has been
categorized as a classical intercalator where it has a flat planer section with a single bulky side
chain. Typically, classical intercalators bind and unbind the DNA rapidly in the order of microsecond time scale. But you will see that our experiments show Doxo binding time scales are
comparable to typical threading intercalators rather than classical intercalators.

Doxorubicin: One of The Most Prominently Used Cancer Therapeutics
As mentioned earlier Doxorubicin (Doxo) has been stamped with the nicknames of Red Devil1
and Red Death2 due to the distinctive hue matching that of blood, and the gruesome side effects
it can cause. Despite this, Doxo and the other drugs part of the anthracycline class, including
daunorubicin (Daun), epirubicin (Epi), and idarubicin (Ida), are still some of the most prominently
used cancer drugs today. Up to 32% of breast cancer patients23, 57-70% of elderly lymphoma
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patients24,25, and 50-60% of childhood cancer survivors are and were treated with the
anthracycline class of drugs26,27. Over the last several decades, a “better anthracycline drug” has
been vigorously searched for without tremendous luck.
Doxo is effective against a plethora of hematopoietic cells (immature cells that can develop into
the different types of blood cells) and solid tumors, including leukemia, breast cancer, soft tissue
sarcomas, childhood, sold tumors, lymphoma, along with several others28 with an exception
being that colon cancer does not respond to Doxo29. Regardless of Doxo’s presence of being a
cornerstone in anticancer therapeutics there is much more to be understood.
To halt cancer, it is necessary to cause the cell to undergo apoptosis (killing itself), and this is
exactly what Doxo can trigger. The manner in which Doxo inhibits cancerous cell reproduction is
the interaction between Doxo and DNA along with topoisomerase inhibition. Doxo, like other
anthracyclines is known to intercalate, in which the drug molecule will have a bulky side part
outside the DNA double helix while its flat-planar aromatic ring system is slid between the base
pairs30 of the DNA. This in turn increases the stacking forces within the DNA base pairs through
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electron transfer, holding Doxo in place once intercalated 31. The structures of Doxorubicin and
Doxo intercalated between DNA base pairs of DNA can be seen in Figure 7 32.

a

b

c

Figure 7: (a) Chemical structure of Doxorubicin (b) two orientations of 3D structure of Doxorubicin
showing the flat planer section and bulky side chain more clear and (c) two Doxorubicin molecules
bound to DNA through intercalation (PDB: 1D12)

This same process inhibits the enzyme topoisomerase II 33, which limits the rotational force of
the DNA during the replication process34.
The intercalation process is left largely mystified because while Doxo intercalates it also
aggregates with itself forming dimers before and while intercalating35-37. This adds a level of
complexity in understanding the exact mechanisms in which Doxo interacts with DNA. Further
complicating the interaction it was reported that aside from intercalating, Doxo (positively
charged in solution) also binds to the major and minor grooves of the DNA31. Furthermore it has
been reported in some cases that Doxo exhibits preferential binding to particular base pairs of
the DNA. 33
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The Red Devil can rear its head in multiple ways, including cytotoxic side effects, therapy-related
malignancies, infertility, cardiac, and bleeding through the palms of the hand and soles of the
feet respectively from palmoplantar disease38. All these negative side effects limit the clinical
application of the Doxo administration39.
The detailed binding characteristics of Doxo to DNA has been reported differently throughout
several published articles, causing intense debate40. In the millimolar range Doxo will aggregate
with itself prior to interacting with the DNA41. In some cases reporting that it forms a dimer36,
and in others it is reported as self-association of 3 to 4 molecules of Doxo35. In either sense this
would alter the reports of the behavior in Doxo and explains the intense debate.
It has also been reported that Doxo first binds to the minor groove of the DNA, then intercalates
itself between the base pairs40. The only single molecule study, in which Doxo is explored is at
low forces (under 10pN), its affinity to DNA is reported as 5.3 ± 0.3 x105 M-1, and a binding site
size of 1.4 ± 0.4 35. In other studies, binding affinity values reported for Doxo binding to the DNA
ranges from nanomolar (2.3 x 108 M-1) to micromolar (9.3 x 105 M-1)36.
For a drug that has been used on countless patients since the 1960s there is much left to be
understood regarding the interaction with DNA. In this study we quantify both the binding affinity
and binding kinetics of Doxo to DNA at the single molecule level. To our knowledge only one
previous study has been reported at the single molecule level and was done only at low force
range using optical tweezers. We use dual-beam optical tweezers which allow us to reach high
forces past the melting transition of the DNA and the ability to provide complete characterization
of the drug at the single molecule level for the first time.
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Introduction to Optical Tweezers
In 2018 the Nobel Prize was awarded to Dr.
Arthur Ashkin for the optical tweezers and
its applications to biological systems42. Dr.
Ashkin along with Dr. Steven Chu pioneered
the creation of the optical trap more than
thirty years ago. Figure 8 shows what the
first optical tweezer looked like that Dr.
Figure 8: Dr. Ashkin (right) working with Dr. Chu (left) in

Ashkin and Dr. Chu were working with, 1986 at Bell Laboratory in New Jersey, USA, to trap and cool
notice the abundance of wires and

atoms using lasers.

additional equipment. In the early seventies, Dr. Ashkin published the theory to use the radiation
pressure of light, to trap and manipulate small particles that would be invisible to the naked
eye43. The theory came to fruition in 1986 when Dr. Chu was able to capture and cool atoms44,45,
which won him the 1997 Nobel Prize in physics for this accomplishment along two other
scientists, William Phillips and Claude Cohen-Tannoudji. One year after the trapping of atom, Dr.
Ashkin was able to trap a single virus and bacterium without damaging it in 198744. The trapping
of biological materials with lasers have been a challenge because water absorbs the energy from
the radiation, heating up, and ultimately killing the sample. Dr. Ashkin overcame this challenge
by using lasers with infrared wavelengths, where the water absorption is at the minimum. In the
years to come, Dr. Ashkin was able to manipulate single cells46, then organelles47. He even
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reported force measurements using the optical tweezers by moving organelles within the cell48.
This opened up a new method to study biological systems at the single molecule level.
In 2014, at BSU a president for optical trapping was set by Dr. Deveney and his students by using
lasers to trap tiny (5 μm) polystyrene beads. Several years later in 2016, undergraduate students
with the guidance from Dr. Thaya constructed a dual-beam optical tweezers set-up that can be
used to conduct single molecule biophysics research. It is believed that this is the first set-up of
this caliber that is constructed and maintained completely by undergraduate students in the
Nation. There are roughly thirty of these set-ups across the world that are constructed in a similar
way.

Understanding the Physics of the Optical Trapping
To understand the physics of trapping with light we first need to understand force created by
momentum change during two main phenomena of light, reflection and refraction.
Imagine an introductory physics problem where there is a truck driving down a road and slams
into a tree, bouncing off. Now think about the light from a simple laser pointer being pointed off
a mirror and reflected in a different direction. What is the similarity between the two events? In
both events the truck and light carry a linear momentum which caused them to bounce off an
object. It is easy to understand that a truck carries linear momentum (mass  velocity), but it is
more complex to imagine that light can also have momentum. This can be explained by
combining quantum mechanics and wave-particle dual nature of light.
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With that said, Newton gave the equation of 𝐹 =

𝑑𝑝
𝑑𝑡

, meaning that there is force that is

represented by the rate of change in momentum. In the previous example the rate of change in
momentum of a truck is much greater than that of a laser, therefore the force associated with
the laser is minute. Although we, as humans, may not necessarily feel a force from a photon there
is a force and pressure applied to a particular location of impact The pressure created by the
𝐹

force is proportional to the force: 𝑃 = 𝐴, where F is force, P is pressure, and A is area. Substituting
for force from Newton’s Law mentioned above you get: 𝑃 =

1 𝑑𝑝
𝐴 𝑑𝑡

. This equation is saying that

there is a particular pressure associated with the laser reflecting off a mirror, this is deemed the
radiation pressure.
Just like the reflection of light can cause change in momentum and in turn result in a force as
discussed above, another phenomenon of light known as refraction can also result in a
momentum change and lead to the creation of force. The speed of light changes depending upon
the medium in which it is propagating through. When light transitions from one medium to
another it will bend, and this is bending of light known as refraction.
Snell’s law describes the bending of light at the interface of the two mediums, which states that
𝑛1 𝑠𝑖𝑛𝜗1 = 𝑛2 𝑠𝑖𝑛𝜗2 , where n1 and n2 are refractive index of the mediums. Mediums are given
refractive indexes based on the speed of light in that medium. The angles θ1 and θ2 are the angle
made by the incident beam and refracted beam respectively with the normal.
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In the case of the optical tweezers, the laser will be passing

Incoming Light
Radiation
θ1

through the liquid buffer medium (with refractive index n1) to
the polystyrene bead (with refractive index n2) as shown in

Reflected Light
Radiation
n1

θ2
Refracted Light
Radiation

figure 9. Since n2 is greater than n1, the incoming ray (red) will
Polystyrene Bead

be refracted (green) towards the normal according to Snell’s

n2

law as shown in Figure 9. Some of the laser radiation will also
Figure 9: Application of Snell’s Law as it

be reflected (brown).

pertains to the optical tweezers.

On the way out of the bead it will bend away from the normal.
The refraction of two symmetric laser rays passing through a

Incoming laser radiation (red) from the
buffer medium, makes impact with the
surface of the bead where part of it is
reflected (brown) and the rest is

bead in the center of the laser beam is shown in Figure 10.

a

b

Gaussian Laser

refracted (green).

Gaussian Laser
60x Objective

60x Objective

Bead

Bead

Net Force on
Photons

Net Force on
Bead

Net Force on
Photons

Net Force on
Bead

Figure 10: Schematics of a laser focused by an objective onto a single micron sized point holding a bead in place
and Ray diagrams explaining the physics. (a) The case where the bead is along the optical axis of the objective and
the enlarged view describing the symmetric rays refracting through the bead. The left inset shows the momentum
changes of both beams (light red arrows) resulting in the net force (black arrow) on photons. The right inset shows
the equal and opposite force acting on the bead. (b)The case where the bead is entering the laser beam from the
left and the enlarged view describes an intense ray from the center of the laser bean and less intense ray from the
edge of the beam getting refracted through the bead. The insets describe the forces on the photons and bead.
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The bending of light while passing through the bead creates the momentum change of the
photon, and henceforth a force of the photon. From this we can figure out the direction of the
net force acting on the bead which will be opposite of that on the photon. The resulting force in
the symmetric case will be in the direction towards the focal point of the objective (Figure 10,
left). When the bead is misaligned and away from the axis of the laser (Figure 10, right), the
gaussian nature of the laser will still trap the bead. That is because the middle part of the laser
emits more intense radiation, therefore it will apply more force on the bead pushing it towards
the center optical axis.

Trapping and Stretching DNA with Optical Tweezers
When the bead that is trapped is pulled out of the trap by a force the laser gets deflected and
that deflection can be measured using detectors and then converted to force measurements.
This concept is used to tag biological molecules to the bead to obtain force measurements. Dr.
Steven Block was able to trap a single DNA molecule and stretch with optical tweezers and
measure the force experienced by the DNA as function of extension in 1997 49. This results in the
force-extension curve commonly known as DNA stretching curve (Figure 11). You can see that
the forces experienced while stretching is in the order of pico-newton (pN), which is 10-12 N and
is very small and comparable to the forces exerted inside the living cell. This makes optical
tweezers a great tool to study the force responses of biological materials.

Introduction | 25

90

ssDNA Regime

80

Overstretching Transition

70

Force (pN)

60
50
40

Hysteresis

30

Elastic Regime

20
10

Entropic Regime

0

0.3

0.35

0.4

0.45

0.5

Extension (nm)

0.55

0.6

Figure 11: DNA stretch (black circles – black solid line) and release (black dashed line) curve with
the four important regions highlighted. Entropic Regime (purple), Elastic Regime (blue),
overstretching transition (green), and ssDNA (yellow). When enough time is not given the DNA
may not properly reanneal resulting in hysteresis while the release (red)

DNA stretching is a reversible process where when it stretched and then given ample time to
return it should return exactly the way it began. The black line in Figure 11 represent the force
measured while stretching the DNA and the black broken line represents the release of the DNA.
At the beginning of the stretching in the bottom left highlighted in light purple in Figure 11 the
DNA is slack with all the base pairs properly annealed. Not much force is needed to stretch it to
its natural length to make it taut. When we make the DNA taut, we are reducing its entropy
therefore this region is referred to as the entropic regime. Once the DNA is taut further pulling
makes the backbone of the DNA respond by beginning to untwist. This phase of DNA stretching
can be modeled similar to that of elastic band, or spring, where the DNA is fighting to be
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stretched50. This second region highlighted blue in Figure 11 is known as the elastic regime. In
the elastic regime there is little extension seen but a large increase in force response from DNA
which increases from near zero to 65 pN. After reaching 65 pN you can see that the DNA length
is almost doubled without much change in the force. This region shaded green in Figure 11 is
labeled as the overstretching transition. There have been multiple models that has been debated
over the year on what’s happening to the DNA in this region51,52. After almost twenty years have
passed since the first DNA stretch, now many agree that the DNA base pairs begin to break and
that causes the greater extension of the DNA without much of an increase from the 65 pN force.
This is referred to as Force Induced Melting (FIM). The DNA goes through a phase transition from
dsDNA to mostly ssDNA at constant force, similar to ice melting into water at constant
temperature. The last regime (highlighted light orange in Figure 11) is the ssDNA regime where
most of the bases of the DNA are broken except regions of the DNA that are GC rich. Upon release
of the DNA from the ssDNA regime the bases begin to reanneal. Occasionally the DNA will not
properly anneal resulting in the hysteresis seen in Figure 11 indicated by the red arrow. Figure 12
depicts a cartoon describing the state of the DNA in each regime of the DNA stretching curve.
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Entropic Regime
Elastic Regime
Overstretching
Transition
ssDNA Regime

Hysteresis
Figure 12: A cartoon representation of what the DNA could look like in each regime of the DNA
stretching process. In entropic regime DNA is in its natural state, bundled and slack. In the elastic
regime the DNA begins acting like a spring resisting stretching. Overstretching transition, the
base pairs begin the melt except for regions that are rich in GC content. In the ssDNA regime

most of the base pairs are broken apart. Upon the relaxation the DNA begins to reanneal back to
its original form, sometimes not matching up perfectly though resulting in hysteresis.

Studying Intercalation using the Optical Tweezers
Understanding how the DNA stretching curve changes when the DNA is stretched in the presence
of an intercalator provides insight into the binding mechanisms and strength of binding. Models
hence have been developed which quantify these interactions between the DNA and these
molecules53. Obviously when intercalators insert their flat parts between the DNA base pairs, the
DNA will have a corresponding lengthening. This DNA lengthening can be seen in the DNA
stretching curves as indicated by the blue arrows in Figure 13.
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Figure 13: DNA stretching curve in the absence (black) and in the presence of an intercalator
(red). Highlighting the associated increase in length (blue arrows) and increase in force
required to melt the DNA (green arrows) in the presence of intercalator.

Imagine you have two glass sheets stacked on top of each other, it is relatively easy to pull the
two apart from one another. Now, add water, that task becomes a lot more difficult than the
previous attempt. The premise is the same with an intercalator when it is added to DNA. Initially
it is easy to pull the DNA apart but when an intercalator is added the task gets more difficult.
As the intercalator inserts itself into the DNA it is increasing the pi-pi bonding between the base
pairs strengthening the DNA. In experiments this is seen through needing an increase in the force
needed to melt the DNA during the overstretching region (Figure 13)18.
Both of these effects, the lengthening of the DNA and increase in the melting force, increases as
we add more intercalators. This is clearly visible in Figure 14 54 where DNA is stretched in the
presence of various concentrations of a classical intercalator EtBr. You can also observe that after
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certain a critical concentration (125 nm in this example) the melting transition disappears

Force (pN)

indicating the impossible nature of melting the dsDNA in the presence of intercalator.

Extension (nm/bp)

Figure 14: DNA stretching in the presence of various concentrations of a wellknown classical intercalator, Ethidium Bromide (colored curves) and in the
absence of the intercalator (black).
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Materials and Methods
Preparation of Biomaterials
In our experiments we use four main biomaterials: buffer solution, polystyrene beads, DNA, and
the drug under investigation (in our case Doxo). All of which requires the buffer solution for
preparation. Our buffer imitates that of the physiological conditions seen inside the body, which
has a pH of 7.4 and a salt concentration of around 150 mM. The buffer solution we prepare is
done so by combining 5.885 g of NaCl, with 10 ml of 10 mM Tris, and 990 ml of Milli-Q water
(special water that has gone through a series of deionization and filtration steps to maintain a
resistivity of 18.2 MΩ cm). The buffer is then filtered and tested to have a pH of 8, slightly more
basic than physiological conditions along with a salt concentration of 100 mM which is slightly
lower than the physiological condition.
The biosafe beads that we use in our experiments are bought from Spherotech. They are 3.11 μm
diameter polystyrene beads that are coated with streptavidin (SVP-30-5).
The lambda phage DNA (48,500 bp) used in
our experiments are purchased from SigmaAldrich and labeled with biotin on the 5’
ends in the lab. This labeling enables the
tethering of DNA to the beads by forming
streptavidin-biotin complex (Figure 15) when
introduced into the system.

4
Streptavidin

Biotin

Streptavidin –
Biotin Complex

Figure 15: Cartoon showing the binding mechanism of
streptavidin and biotin that allows the biotin labeled DNA in
our experiments to chemically attach with streptavidin
coated beads.
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Doxo was bought as a powder from Fisher Scientific (AAJ64000MA) and a stock solution of
11.49 mM was made by adding 10 ml buffer. By taking 4.35 μL from the stock and mixing with
495.65 μL a sub-stock solution of 100 μM. Before every experiment was carried out the substock eppendorf tube was vortexed well to assure the solution was properly suspended. This was
done because the drug could have been sitting for a long period of time in between experiment,
and because we read that the drug can aggregate in the millimolar range. Although that is far
away from our micromolar range we did so out of precaution. The concentration of the drug was
also occasionally double checked with absorption spectroscopy. For each experiment, the exact
concentration of Doxo needed was calculated by hand and then assured using a calculator built
into our data analyzation program. The solution was then made in the reservoir tube and ready
to be used in the experiment once mixed.
The buffer is stored in a sterile 1 L plastic container at room temperature while the rest of the
biomaterials are stored in a temperature-controlled refrigerator at 4°C. Upon need of a particular
biomaterial, it was removed from the refrigerator prepared, pipetted in the respective reservoir
tube and then immediately placed back into the refrigerator for preservation.

Dual-beam Optical Tweezer Set-up in the Single Molecule Biophysics Lab
The SMB Lab, where the optical tweezer set-up is kept, is in a temperature-controlled room at
25°C. The entire set-up is built on an optical table that roughly weighs 800 pounds which sits on
four cylinders that are supplied with air from an external compressor. This air then causes the
table to rise and float allowing for the system to be isolated from vibrations in the environment.
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Since the forces measured in our experiments are in the order of pico-newtons any vibrations
that come from walking down the hallway, or to doors slamming in the building will have to be
isolated and the optical table does this job. Any vibrations or changes in temperature will also
alter the laser alignment, which is exceedingly difficult to obtain in the first place. An image of
the optical tweezer set-up at BSU can be seen in Figure 16.

Figure 16: The dual beam optical tweezer set-up at BSU. The laser which is not actually visible is

depicted here with red line to visualize the laser beam path.

In our dual-beam optical tweezer, a single beam from laser gets split up into two separate
pathways and then gets finely focused onto a single micron sized point. A micron sized point is
equal to one-hundredth of the thickness of a single piece of your hair. The reason for the dualbeam optical set-up opposed to a single beam apparatus allows for us to reach higher forces.
Figure 17 represents a bird’s eye view of the details and components involved in making the
functional dual beam optical tweezers at BSU.
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Figure 17: Schematic of the dual beam optical tweezer set-up and the components used at BSU

We use a single butterfly laser diode to produce a beam that is just out of the visible spectrum of
light and in the inferred spectrum. A full component break down of the components of our table
can be found in55. The 275 mW beam, linearly polarized to be vertical to the table exits through
the fiber port, travels to the right on the diagram to the first beam splitting cube where the single
beam now becomes two with equal power. Each beam then encounters a series of mirrors to
reach the polarizing beam splitting cubes (shaded in green) at the bottom of Figure 18Figure 17.
Disregard the blue lines on the edges of Figure 17 for the moment and continue to follow the red
laser line on the left.
The polarizing beam splitting cube is designed in a manner to split an un-polarized laser into two
perpendicular linearly polarized beams. When its reflecting plane is placed at 45° to the incident
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beam such that the plane is vertical (Figure 18)55, polarized vertically, and the transmitted laser
will be polarized horizontally.
In our set-up the green colored polarizing cube
is used primarily to steer the vertically
polarized laser in the direction of the objective
through reflection. The second polarizing beam
splitting cube (color coded in blue in Figure 17)
is placed in an orientation such that the
Figure 18: The beam splitting polarizing cube reflects

vertically polarized beam will be transmitted
and any horizontally polarized light to be

the vertical polarization that is parallel to its
reflecting plane (green) and transmits the horizontal
polarization (yellow) through the cube.

reflected directly up towards the director.
Therefore, our vertically polarized beam from the left will be transmitted through the cube to
reach the quarter wave plate.
The quarter wave plate will alter the polarization of the beam making it circular before entering
the objective. The objective then focusses the laser inside a microfluidic flow chamber that we
call the flow-cell, where we trap the beads and the DNA to conduct our experiments. The
objectives used in our set-up have 60x magnification with a working distance of 2 mm and a
numerical aperture of 1.2. Numeral aperture is measure of how the light is bent while focusing
the laser and depends on the refractive index of the medium. Higher numerical aperture will
result in a stronger trap.
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When the laser passes through the trapped polystyrene bead and emerges out from the opposite
objective it will pass through the other quarter wave plate (on the right) making the laser linearly
polarized again but with a 90° rotation. This means that after the laser passes through both
quarter wave plates (through the objectives) it will be horizontally polarized.
As the horizontally polarized laser then encounters the polarizing beam splitting cube on the right
side of the objective (color coded blue in Figure 17) it will be reflected towards the diode detector.
A lens with a particular focal length and an intensity filter prior is used to focus the laser into the
diode detector and protect the diode from high intensity. This diode detector measures the
deflection of the laser and from that we can extrapolate the corresponding forces.
Now consider the blue line that represents the light that comes from the blue LED on the left
side. This provide collimated light to the objectives to illuminate the flow-cell, which will be
discussed shortly. This light then is directed to the opposite camera to provide the image inside
the flow-cell. All the optical components discussed above will not have any effect on the blue
light because of its random polarization.
An achromatic lens prior to the camera is used to focus the image and a particular bandpass filter
is used exclude the unwanted light entering the camera. This unwanted light would distort and
take the image impossible to see. These cameras are projected into a computer screen that allow
for us to visualize and manipulate the experiment.
The laser beam and blue light travelling in the opposite direction will follow a similar path as
described above for the beam travelling from left to right.
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The Flow-cell
Our entire experiment is conducted in what is called a flow-cell which can be seen in Figure 19.
These flow-cells are hand constructed at BSU where we get the plexiglass spacer from the
machine shop with three holes drilled in it (the micropipette tip hole, waste tube hole, and a hole
for the four inlet tubes) and a hollow channel in the middle. The flow-cell is then cleaned using
dish soap and dried, then further cleaned using methanol. This is done rigorously to remove any
oils or contaminants from the milling process.

Syringe Connecting Tubing
Micropipette
Inlets

Waste Tubing

Figure 19: A hand-constructed plexiglass flow-cell with four inlet tubing (left) that
allows to the flow the biomaterials, a waste tubing (right) which collects the liquid
waste from the experiment and micropipette tip (top) inserted into the flow-cell
through vertical channel and connected to a syringe.

An optical adhesive (NOA68, 6801, Norland Products) is added to one side of the plexiglass spacer
evenly and microscope cover glass slide (22 x 30 x 0.13 mm, 12-545A, Fisher Scientific) is then
placed precisely and carefully on the adhesive. Its then exposed to UV light for 45 minutes to cure
the glass slide to the plexiglass spacer. This process is repeated for the other side to obtain a
chamber.

Methods | 37

A borosilicate glass micropipette tip (TIP1TW1, World
Precision Instruments) is then inserted through the top
vertical channel. Inserting this glass tip takes precision
and requires the use of a microscope with 100x
magnification to slowly move the tip down the channel
hole. Any bumping of the tip on the side of the channel
will cause the single micron sized tip to crack, ruining Figure 20: The micropipette tip inside the flow
the entire flow-cell causing a restart of the process.

channel viewed under a 100x microscope.

Figure 20 shows the image of the tip under the 100x microscope. The micropipette glass tip is
adjusted until it is placed directly in the center of the main flow chamber. Once perfectly placed
a dab of the optical adhesive is used and exposed to the UV light for 45 more minutes to secure
the tip in place.
After the curing process a diamond tipped pen is used to break the excess of the micropipette tip
leaving only a single centimeter exposed. A 7-inch long piece of Tygon® Microbore tubing, with
inner diameter of 0.020” and an outer diameter of 0.060” (EW-06419-01, Cole-Parmer), is used
to fit directly around the micropipette end. It is then sealed with optical adhesive using the same
procedure as before.
Next the four BD Intramedic Polyethylene tubing (PE10, VWR) are inserted to one of the sides of
the flow-cell to be used as inlets. These four tubes are cut to be about 8 inches long and have an
inner diameter of 0.011” and an outer diameter of 0.024”. Once placed through the hole into the
flow-cell chamber it is important to carefully maneuver the tubes to the edge of the hole not
having too much of the tubing inside the chamber. Having too much tubing inside the chamber
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or not aligned with the edge of the drilled hole will cause turbulent flow of the biomaterials. The
optical adhesive and UV light procedure is once again carried out once the tubing is placed
properly. The reason to have four inlet tubes is for the four types of biomaterials needed to carry
out the experiment. Buffer, polystyrene beads, Λ-DNA, and the drug of interest that is being
studied.
Finally, nearly a 12” long BD Intramedic Polyethylene tubing with a inner diameter of 0.045” and
an outer diameter of 0.062” (PE 160, VWR) is inserted into the third hole of the flow-cell to serve
as the outlet tube (waste tube). Similar to the four inlet tubes the waste tube needs to be places
perfectly in the remaining side hole to the flow-cell chamber. Once placed, again the adhesive
and UV light combination are used to seal. The flow-cell is now ready for experiments. The
replacement of the flow-cell is required only when the drug in the chamber and cannot be
completely washed away with buffer and a molecular cleaner, Tween, (this commonly happens
at high concentrations of Doxo) or when the flow cell leaks.

Biomaterial Reservoirs and the Flow Control Process
The biomaterial reservoirs are used to feed the flow-cell the needed biomaterial through its inlets
during the experiments. These reservoirs are designed with 15 ml tubes with a custom drilled
hole in the bottom of them (the holes are drilled in the machine shop).
The same type of tubing that is used for the waste tube of the flow-cell is used as the outlet of
the reservoirs. A 9” piece is placed inside the hole and sealed using the optical adhesive and UV
light to cure. Each of the four reservoirs are then placed in a special designed biomaterial
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reservoir holder to hold each one independently.
This is a custom-built reservoir holder designed by
SMBL lab members in 2017. Each tubing is then
placed through separate clamp gates (circled in
yellow in Figure 21). In addition to allow the flow
the clamps are used to prevent backflow into the
reservoirs when they are not in use.
The way we are able to flow the desired fluid at a
particular time is due to the fact of compressed air.
Each reservoir has a cap that is attached to a tubing

Figure 21: The clamps (circled in yellow) that

serves at gate for biomaterial flow from the
reservoir. The tubing attached to the caps of the

(circled red in Figure 21) and connected to a
solenoid valve. The solenoid valves are connected

reservoir tubes (circled in red) connects to
compressed air flow.

to the compressed air system and controlled by a
custom-built electrical flow control box (built by me
in 2018). With a flip of a switch from the electrical
flow control box (Figure 22) it is possible to flow the
desired fluid into the flow-cell. When the desired
switch is flipped on the flow control box it will causes Figure 22: Custom designed flow control box to
flow our four biomaterials. Upon flipping of a

a solenoid to displace allowing air to flow through
the valve into the tubing that is connected to the cap

single switch, it will induce the solenoid (not

shown) to move a magnetic clamp allowing for
compressed air to flow through the tubing to

of the reservoir. This air pressure will push the

the reservoir holders at adjustable pressure.

biomaterial in the reservoir into the flow-cell.
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Connecting the Flow-cell to the Biomaterial Reservoirs and cleaning
Once the flow-cells and the biomaterial reservoirs are completed they should be connected, and
a series of tasks must be completed prior to the start of an experiment. The edges of the tubing
to the four inlet tubes are trimmed diagonally to assure that we do not get any dust or other
contaminants into our system. This freshly cut tubing is then connected to the tubing that comes
out of the reservoir tubes as shown in Figure 23. The waste tube is connected to the waste
container, and the tubing from the micropipette tip is connected to a syringe.

Figure 23: The flow cell inlets connected to reservoir tubing (circled in yellow), the waste tubing
connected with waste connected with waste container and micropipette tubing connected

with the syringe.

The new flow-cell that is attached to the biomaterial reservoir system is flushed with two
milliliters of buffer from each of the four different reservoir tubes independently. This flushing
with buffer accomplishes cleaning the system of any dust particles or unseen contaminants. Once
the flow-cell is flushed then a little bit of buffer is added in all four reservoirs and flowed through
the tubing. But this time the purpose is to fill the system with buffer such that there are no air
pockets or bubbles in the system.
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Are we ready for the experiment yet?
Now that the flow-cell has been properly hooked up the
reservoirs, washed out and filled with buffer we are now ready
to place the flow-cell between the microscopic objectives. The
flow-cell is placed on a moving stage that can be manipulated
by hand and piezoelectric controller. This must be accomplished
using steady hands, and precision without scratching the

Figure 25:The flow-cell dock and
clips that hold the flow cell in place

objectives. As seen in Error! Reference source not found. the

mounted in the piezoelectric stage.

stage clips (yellow arrows) are separated to wedge in the flowcell between them and the whole flow-cell is then slid down into
the clamps.
The reason for such diligent work is that if the objectives are
bumped or displaced the alignment of the laser will have to be
redone which can take hours to up to weeks to fix. The stage
(Figure 24) allows for manual movement of the stage in three
Figure 24: The stage (front) that is

dimensions along with fine nanometer movements in one used to mount the flow-cell. The two
direction. A piezoelectric crystal within the stage that expands

shorter length knobs (coming
towards the front and left) are for

or contracts with applied voltage allows for the fine movement manual control and the longer knob
of the stage in one direction. During experiments this is
controlled by the computer program to move the stage to

coming towards the front can be

manipulated both manually and by
the computer.
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stretch the DNA. Now that we have the flow-cell docked on the piezoelectric controlled stage,
we are ready for the real action.

Lights, Camera, Action
Before turning on the laser we need to understand the
operation conditions of the laser. The laser selected for
the optical tweezers contains particular characteristics
necessary for the functioning of the experimental set-up.
The laser used in the BSU SMB lab is a butterfly diode laser
that is housed in a compact LD and temperature controller
as seen in the Figure 26. The controller is hypersensitive
to electrical surge so before touching it is of up most

Figure 26: Laser controller that houses the
laser that is used for the optical tweezers.

importance that the researcher grounds themselves before turning on the controller. As the laser
controller boots up to the screen seen in the figure 26, the internal temperature is set to its
operational temperature of 25°C. Once the temperature reaches this value, the laser warning
sign at the entrance of the lab is turned on for safety, and then the laser is turned on. The laser
has a power of 250 mW and a wavelength of 785 nm which is just outside the visible spectrum
towards inferred. The laser transmits through all the optical elements as discussed earlier in the
optical tweezers set up.
To see the image of the flow-cell while the experiment is happening, we use blue LEDs on both
sides of table (as we discussed earlier, Figure 17). These blue LEDs are used to illuminate the flowcell allowing for an image to be created in the camera. There is an adjustable setting on the blue
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light that allow us for the brightness to be adjusted as needed. These cameras are connected to
a computer above the optical tweezers dedicated to process the camera image. Through a
program we can select which camera we would want to see on at a specific time. Throughout the
experiment we shuffle back and forth from one camera to the other.

The Game Plan
The overall idea of the experiment is to trap a bead with laser and attach it to the micropipette
and trap another bead to be held by the laser. After trapping the beads, DNA is flown through
the flow-cell and a single DNA molecule is chemically attached between the two beads. The DNA
is stretched to check if it is a good candidate for experiments. If it is good DNA the drug is added
to the system and then the DNA is stretched in the presence of the drug. Figure 27illustrates the
main steps of the experiments, which will be discussed in detail in the coming sections.

Figure 27: Process of catching a single molecule of DNA inside a flow cell with optical tweezers. (a) Polystyrene
bead caught in laser trap. (b) First bead attached to micropipette tip and second bead is captured in the laser
trap. (c) DNA is introduced into the system and one end is attached to the bead in the trap. (d) Other end of the
DNA is attached to the bead on the micropipette tip and drug introduced into system.
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Trapping Bead and Checking the Laser Alignment: Obtaining a Stiffness Curve
The first step of our experiment is to check the strength of our trap and fine alignment. This is
done by trapping a bead and obtaining a curve called stiffness curve.
The bead reservoir is filled with 2 ml of buffer and 2 μl of 3.11 μm polystyrene beads coated with
streptavidin is added and vigorously mixed so that the beads are equally distributed throughout
the reservoir tube. The beads flow is turned on until a bead is trapped.
The trapped bead is then attached to the
micropipette tip via suction using the
syringe and the rest of the system flushed
of stray beads. The bead on the
micropipette tip is moved across the laser
spot using the computer program to
obtain the trap-stiffness curve (figure 28).
In the trap-stiffness curve although the yaxis is marked “force” and the x-axis is

Figure 28: Screenshot of our program showing a stiffness
curve obtained prior to an experiment. The blue and green

marked “position”, you will see that the
units of the force is marked as microns.

dots represent the deflection of the laser as the bead passes
through the laser spot by the detectors on either side.

The reason behind this is the program is essentially plotting the deflection of the laser beam due
to the bead moving into the trap. The reason we see two different plots (blue and green) on the
graph is because we have two diode detectors on either side (refer to Figure 17). The solid circle
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represents the micropipette tip moving away from the origin initiated while the open circle
represent the return. If the alignment is perfect, both plots should overlap and most importantly
both curves should have the same slope. If they do not overlap, fine laser alignment is needed
and carried out by adjusting the fine adjustment controls for the piezoelectric stage.
Once we have the alignment done, we move the bead attached to the pipette away from the
laser spot and trap another bead with the laser. The system is then flushed of the stray beads
with the buffer. Now we have two beads one attached to the pipette and the other trapped and
held by laser. We are ready to catch a single DNA molecule.

Let’s Go Fishing: Catching a Single DNA Molecule
The DNA reservoir is filled with nearly 2 ml of buffer and 2μl of the biotin labeled Λ-DNA (48,500
base pairs) is added. One may think that adding more DNA will enable the DNA trapping process
to be easier but having too much DNA in the reservoir will cause havoc in the system. The DNA
will aggregate with each other, stick the flow-cell, and saturate the experiment rendering it
useless. Therefore, it is important to find the right balance between having enough vs having too
much. It is important to be very gentle with the DNA unlike the beads. The DNA should be mixed
slowly with the 1 ml pipette assuring no bubbles are put into the reservoir tube.
Using the manual controls for the piezoelectric stage we moved the bead attached to the
micropipette tip about 6 μm away from the one in the trap. Then the DNA is flowed into the
system, allowing it to bind to the bead in the trap. Once one end of a DNA is attached to the bead
in the trap the free end will be floating with the flow. By preforming a series of circular
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movements, we can attach the floating end of the DNA to the bead attached to the tip. Resulting
in a single DNA molecule between the two beads (Figure 29). Once a single DNA molecule is
trapped the stray DNA is rinsed by flowing buffer through the flow-cells. We are now ready to
stretch the DNA.

Figure 29: A cartoon DNA (blue) drawn on top of the actual image seen during experiments.

Playing Tug-of-War with DNA
The parameters on our computer program that controls the data collection are then set to take
100 nm steps and wait for 75 ms after each step to collect 1000 data points from the diode
detector at each step. Based on the initial point the total number of steps is also given to the
program so that the DNA can stretch through the entire melting transition. As the bead on the
micropipette tip is moved away from the trap (to the left in Figure 29), the bead in the trap will
slightly move (to the left) as well indicating there is a DNA molecule between the two. In real
experiments we won’t be able to see the DNA but I have drawn a cartoon DNA in Figure 29 to
make it easy to visualize. As the bead in the trap shifts due to being pulled by the DNA, the laser
deflection is measured by the diode sensors. The stretching curve produced is checked with the
Methods | 47

standard DNA stretching curve (shown in the introduction, Figure 11). If it does not match that
means it is not a good piece of DNA, thus unusable for an experiment. In the unusable case, the
system would then be flushed with buffer and air from the syringe. We then would then start the
experiment from scratch beginning with placing the flow-cell into the stage clips. We analyze this
curve based upon two models: worm like chain and freely jointed chain model that are discussed
in appendix 2.

Stretch and Release Experiments with DOXO
Once we have a good single DNA molecule attached between the beads, we are ready for our
real experiments. The concentration of Doxo is made to make a 2 ml solution with buffer within
the drug reservoir. Then 1 ml of this drug solution was allowed to flow through the flow-cell
before the flow was turned off. This was to assure that the flow-cell chamber was filled with our
desired concentration of Doxo. The DNA is then stretched and released by keeping the same
parameters used to stretch the DNA without drug (100 nm step size with a 75 ms wait time at
each step, averaging a 1000 data points at each point). This procedure was repeated at several
concentrations and at least 3 times for each concentration of Doxo to check the reproducibility
(shown in the results section). From the literature study, we believed that Doxo should behave
as a classical intercalator, that means it would bind and unbind to the DNA in microsecond time
scale. If true, the stretching and releasing of the DNA in the presence of Doxo should have
overlapped each other, meaning it is in equilibrium, and we should not see any type of hysteresis.
But to our surprise we saw hysteresis which became even more prominent as the Doxo
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concentration was increased (data shown in Results section).The fact that the stretch and release
curves do not overlap can be attributed to Doxo needing an extended period of time to bind and
unbind the DNA. To test this hypothesis, we switched to a technique called constant force
experiments.

Constant Force Experiments
Constant force experiments is a type of experiment that is designed to stretch and hold the DNA
at a constant force while allowing the drug binding to reaching an equilibrium. Initially the DNA
is stretched quickly until it reaches the desired force that the user inputs into the program. As
the drug binds to the DNA, it obviously will extend the DNA and cause a slack which in turn creates
a slight drop in force. In the constant force experiment the program is designed to counter act
this decrease in force by stretching the DNA further. The program is created using a force
feedback loop capable of holding the DNA to the desired force with the precision of 1 pN (this
value is deemed force threshold and can be changed). This allows for us to collect data that
describes the extension of the DNA as a function of time in the presence of Doxo at the desired
force (data shown in Results section). These experiments unlike the stretch and release would
take up to 30 minutes to complete. Apart from the parameters discussed already (step size, step
time, and desired force) we additionally could enter in number of iterations desired. The number
of iterations corresponds to how many steps will be taken at the desired force to reach
equilibrium, ultimately determining the length of time the experiment took. Unlike the stretch
and release experiments Doxo would be continuously flown at a steady rate until the Doxo-DNA
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complex reached equilibrium. After we see that the drug-DNA binding has reached equilibrium
the drug flow is stopped, and the buffer is flown. This will wash away the drug from the system.
Constant Force experiments allows us to quantify the binding kinetics of Doxo to DNA in addition
to their binding affinity.

Safety
There was a great deal of training required to before conducting experiments. Proper laser safety,
chemical safety, and hazard management trainings were paramount. As a lab member I had to
take a short course and pass a safety exam yearly to fulfill the requirements of BSU and
Northeastern University.
When working with Doxo safety is paramount. Anti-cancer drugs also affect healthy cells, so any
time the drug was in use surgical gloves were used. Streptavidin on the beads, Λ-DNA, and biotin
is a vitamin, are labeled as non-hazardous chemicals on SDS data sheets, but again surgical gloves
were used at all times handling chemicals to form good habits.
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Results
Binding of Doxorubicin in Stretch and Release Experiments
As discussed in the methods section, at the beginning of the project stretch and release
experiments were completed for various concentrations between 0.07 nM and 15 nM of Doxo.
At each concentration, the experiment was repeated multiple times, each time with a new single
DNA molecule. Figure 30a shows the stretch (purple solid curves) and release (purple broken
curves) from multiple DNA molecules in the presence of 0.7 nM Doxo is plotted onto a single
graph. The DNA stretch and release in the absence of Doxo is represented by the black solid and
broken curves respectively. As you can see all stretch-release curves from 6 different DNA
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Figure 30: The DNA stretch (solid black curve) and release (broken black curve) is used as reference to compare
the stretch (solid purple curve) and release (broken purple curve) curves of DNA molecules in the presence of 0.7
nM Doxo. (a) represents multiple DNA molecules in the presence of Doxo mostly overlapping on top of each other
and (b) the average of those DNA molecules, both showing lengthening of DNA and slight increase in the melting
transition in the presence of Doxo.
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molecules shown in Figure 30a looked pretty similar and almost overlaying on top of each other.
Therefore, we averaged them to obtain a single extension vs. time graphs for the 0.7 nM Doxo
concentration, which is shown in Figure 30b.
As expected with classical intercalators, in Figure 30 we clearly see that the DNA is extended upon
binding to Doxo and a slight increase in melting force during the stretch. But the stretch and
release curves of the DNA in the presence of Doxo clearly do not overlap. As discussed previously,
in the introduction and in the methods, the stretching of DNA is a reversible process where it
should reanneal on the return. When in the presence of a classical intercalator, the DNA-drug
complex should equilibrate in the microsecond time scale, thus it should also have overlapping
stretch and release curves. The fact that this is not the case means Doxo requires more time to
bind completely to the DNA. This behavior is unconventional for a classical intercalators and since
almost all literature cites Doxo as classical intercalator we were stumbled upon our first results.
An identical procedure was repeated with 7 nM concentration of Doxo to see whether our results
at 0.7 nM make sense. Figure 31 shows the averaged stretch (solid blue) and release (broken
blue) curves of multiple experiments where a single DNA molecule was in the presence of 7 nM
Doxo. Now we clearly see a huge hysteresis. Also, the lengthening of DNA during the stretch with
7 nM Doxo did not change much from the values we obtained for 0.7 nM Doxo. If Doxo did bind
fast to DNA while stretching, with 10-fold higher concentration we should see clear increase in
lengthening. But the extensions observed during the return with 7 nM Doxo was definitely
greater than that obtained with 0.7 nM Doxo. This supported our previous hypothesis that Doxo
needs more time to bind the DNA.
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Figure 31: DNA stretch and release curves in the absence of drug (black) and in the presence of
7 nM Doxo (blue) showing increase in the melting transition and clear extension of DNA-Doxo

complex during the release. The blue curve is an average of 5 different DNA molecules.

Additionally, in both cases (0.7 nM and 7 nm Doxo concentrations) as the DNA was stretched
through the melting transition in the presence of Doxo it resulted in a greater extension of the
DNA upon return (represented by the purple and blue dashed lines in Figure 30b and Figure 31
respectively). This added another piece to the puzzle, whether it means that the DNA needed to
melt to get adequate binding of Doxo to DNA, to reach the equilibrium state. Classical
Intercalators do not require the melting of the base pairs in DNA to bind typically, this made our
results go against a well believed trend for a drug that has been studied since the 1970s. We
continued the same experiments at various concentrations above and below our initial 0.7 nM
Doxo concentration. Interestingly all our experiments followed the same pattern as discussed
above.
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The plot of release curve averages obtained at various concentrations (figure 32) exhibited
classical intercalator behavior. Both the lengthening and melting force of the DNA increased with
Doxo concentration. But the main difference being we observe this in the release curves not in
the stretching curves as observed for all other classical intercalators 53,54,56. As mentioned earlier,
it can be two factors that cause this. It can be either Doxo is binding slow or it needs the DNA to
melt to bind. To explore these features further we switched our experiments from the stretch
and release method to the constant force method.
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Figure 32: : The average release curves of several concentrations of Doxo (dashed colored) with
the DNA stretch and release curves (black) not in the presence of drug used as reference.

Constant force experiments
Through constant force experiments we can stretch the DNA and hold at a constant force (less
than the melting force) allowing the drug to reach an equilibrium without going through the
melting transition. When the DNA is held at constant force there is a corresponding extension of
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the DNA upon the binding of the drug. The DNA-drug complex should then increase in length
reaching an equilibrium. The final length of the DNA-drug complex is referred to as equilibrium
extension (𝐿𝑒𝑞 ).
Constant force data obtained in the presence of 27 nM Doxo being held at 20 pN is shown in
Figure 33a. In these experiments the normal stretch and release curve of the DNA molecule in
the absence of the drug (black) is obtained first and then the DNA is stretched to the desired
force and the drug is introduced to the system. The extension of the DNA as the drug binds
(orange, Figure 33a) is observed.
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Figure 33: Constant force measurements at 20 pN in the presence of 27 nM Doxo (a) DNA stretching
curve (black) in the absence of Doxo and the extension of the DNA that is being held at 20 pN constant

force while flowing 27 nM Doxo (orange). (b) the same DNA extension upon the binding of Doxo
plotted as a function of time (c) the force measurement while the DNA is being held indicates how well
it is maintained as a constant over the duration of the experiment
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During the data collection the force and extension are recorded as function of time. Figure 33b
illustrates the plot of extension as a function of time, which clearly shows the DNA elongating,
reaching an equilibrium extension. The plot of force vs time (Figure 33c) assures a constant force
(19.9 ± 0.4 pN) was maintained throughout the experiment.
The extension of the DNA-Doxo complex as a function of time (Data shown in Figure 34) can be
fit to the following equation:
𝐿(𝑡) = 𝐿0 + 𝐿𝑒𝑞 (1 − 𝑒 −𝑘𝑡𝑜𝑡𝑡 )

(1)

Where 𝐿0 refers to the contour length of the DNA without the drug, 𝐿𝑒𝑞 is the equilibrium
extension of the DNA-Doxo complex, and 𝑘𝑡𝑜𝑡 is the total binding rate of Doxo to the DNA.
Contour length of DNA refers to the length of the DNA molecule at the particular external
stretching force applied. This value can be obtained from the worm like chain model, the
standard dsDNA polymer model (Appendix 2).
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Figure 34: The DNA extension upon binding to Doxo while held at constant force 20 pN in the presence
of 27 nM Doxo (open circles) the theoretical fit (solid curve) corresponding to the equation (1)
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The theoretical fit (solid line in Figure 34) for the data (open circles in Figure 34) was obtained
based on the equation above by changing two fitting parameters, 𝐿𝑒𝑞 and 𝑘𝑡𝑜𝑡 . The fitting
parameters are automatically varied to minimize the sum of chi-squares using the built-in solver
function in Microsoft Excel. A value for chi-square for each data set was estimated by the
following equation:

𝜒2 = [

𝐿theoretical − 𝐿experimental
]
𝛿𝐿

(2)

Where, 𝛿𝐿 is the uncertainty in the measurement of extension.
This procedure was repeated with multiple DNA molecules (5-6) at 20 pN constant force in the
presence of 27 nM Doxo to then obtain an average value for 𝐿𝑒𝑞 and 𝑘𝑡𝑜𝑡 . The standard deviation
of the data was recorded as the uncertainty of the measurement.
The overall procedure was repeated at several concentrations at four different constant forces,
20 pN, 30 pN, 40 pN and 50 pN representing the elastic regime of the DNA. Representative data
and fittings at several concentrations at these 4 forces are shown in Figure 35.
As seen in the extension vs time plots at all four forces (Figure 35), as the concentration of Doxo
is increased the equilibrium extension of the DNA-Doxo complex also increases. Ideally these
values of equilibrium extensions obtained from the fitting in the constant force experiments
should match that of the release extensions obtained from the stretch and release experiments.
Fortunately, in most cases they do match within the uncertainty, indicating that the release
curves were close to equilibrium. Appendix 3 compares the extensions obtained in constant force
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measurements and release extensions obtained from stretch and release experiments. The
equilibrium extensions obtained in the constant force measurements are used to determine the
binding affinity of Doxo intercalating which will be discussed in the next section.
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Figure 35: Representative data for the DNA extension as a function of time under the various
concentrations of Doxo at the four different constant forces studied. The open circles represent the
experimental data averaged while the solid line represents the fit corresponding to equation (1).
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Binding Affinity of Doxo
The strength in which a drug binds with the DNA is defined as its binding affinity. In biophysics
and biochemistry, the binding affinity is commonly expressed in terms of dissociation constant,
𝐾𝑑 , which is the inverse of binding affinity.
To find the dissociation constant first we find the fractional binding of a drug at a certain
concentration at the particular force. Using the 𝐿eq values from the extension vs. time fittings we
can calculate the fractional binding (𝜃) at particular forces and concentrations with the following
expression:

𝜃(𝐶, 𝐹) =

𝐿eq (𝐶, 𝐹) − 𝐿0(𝐹)
∆𝐿sat(𝐹)

(3)

Where 𝐿0 is the contour length of DNA in the absence of the drug, and ∆𝐿sat is the maximum
elongation observed at the particular force when the DNA molecule is saturated with Doxo.
The fractional binding can be used in accordance with a one-dimensional lattice binding model
called the McGhee Von Hippel (MGVH) Isotherm57 to obtain Doxo’s dissociation constant at a
particular force. Please view appendix 4 for more detail of this model and its applications. The
MGVH model provides the following recursive equation that predicts the fractional binding (𝜃)
change with concentration (𝐶) as a function of two important binding parameters, the binding
constant (𝐾d) and the binding site size (𝑛) at a particular force.
𝐶
𝑛(1 − 𝜃)𝑛
𝜃(𝐾d, 𝑛) =
𝐾d (1 − 𝜃 + 𝜃)𝑛−1
𝑛

(5)
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The fractional binding refers to the fraction of base pairs with ligands bound at equilibrium,
compared to the maximum bound at saturation. This means it can only hold a value between 0
and 1. This fitting was done with Microsoft Excel’s Data Analysis tool, solver, with fitting
parameters 𝐾d and 𝑛. But to obtain best 𝐾d values for each data set the value of n was extracted
from literature and was set to a value of 1.4. 𝐾d refers to the concentration in which the DNA is
50% saturated with Doxo, henceforth meaning that a low dissociation constant is linked to a high
binding affinity.
Figure 36 illustrates an example of MGVH fitting (solid line) and the equilibrium extensions that
were used to estimate the fractional bindings (open circles) for various concentrations of Doxo
at the 20pN force.
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Figure 36: Extension of DNA upon binding to Doxo in the presence of various concentrations of Doxo
at 20 pN (open circles) and the best fit to the MGVH isotherm at 20 pN (solid curve).
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This procedure of fitting the fractional bindings to MGVH model was repeated at 30, 40, and
50 pN forces to obtain 𝐾d at each force. Figure 37 shows these fittings (solid lines) with the
equilibrium extensions that are used to estimate the fractional bindings (open circles) at all four
forces that the constant force measurements were done. As mentioned before, each data point
is an average measurement from at least 3 separate DNA molecules and the error bars represent
the standard deviation.
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Figure 37: Equilibrium extensions associated with the fractional binding of Doxo at various
concentrations at all four forces studied (open circles) and fits to the MGVH isotherms at
20, 30, 40, and 50 pN. Each concentration is color coded with different color.
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Force Dependence of Binding Affinity
Once a value of 𝐾d is obtained for all the different forces we can extrapolate its force dependency
to obtain a 𝐾d value that is in the absence of force.
Previous single molecule studies19,22,54,56,58 have shown that the force (𝐹) exponentially facilitates
the binding of a drug molecule to the DNA by stretching and extending it by a length 𝛥𝑥𝑒𝑞 . This
extension is associated with a single intercalation event and in fact the work done to reduce the
energy barrier for a single intercalation is represented by 𝐹𝛥𝑥𝑒𝑞 .
This provides us a thermodynamic exponential model:

𝐾𝑑 = 𝐾𝑑 (0)𝑒

−𝐹𝛥𝑋𝑒𝑞
(
)
𝑘𝐵 𝑇

(6)

Where 𝑘𝐵 is Boltzmann’s constant and T is the temperature in K (294 K in the case of our lab
which yields 𝑘𝐵 𝑇 = 4.06 pNnm). The fitting is done with minimizing 𝜒 2 to find the best fitting
values of 𝐾𝑑 (0) and 𝛥𝑥𝑒𝑞 .
The 𝐾d values were obtained at all the four forces and are represented on the Figure 38 as open
blue circles. The exponential force dependency is shown as the broken blue line where the y-axis
is on a logarithmic scale.
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Figure 38: Force dependent analysis of 𝐾d values obtained at various forces using the MGVH fits
(open circles) extrapolated to get the dissociation constant in the absence of force, 𝐾d(0).

The y-axis intercept yields the binding affinity of Doxo in the absence of force, 𝐾𝑑 (0) = 1087.3 ±
187.4 nM. The 𝛥𝑥𝑒𝑞 value that represents the extension of the DNA per a single intercalation
event was determined to be 𝛥𝑥𝑒𝑞 = 0.40 ± 0.02 nm. The value of 𝛥𝑥𝑒𝑞 obtained for Doxo is
comparable to that of the ones obtained for the threading intercalator, Ru-ΛΛ-P studied by
Adam Jabak and Nicholas Brydan19,58. This value is greater than the other classical
intercalators53,54,56.

Doxo Binding Kinetics (Forthcoming)
The other parameter obtained from the extension vs time fittings of contact force experiments
is the total rate, 𝑘𝑡𝑜𝑡 , representing the net binding rate of Doxo to the DNA. It is the addition of
both on rate (𝑘𝑜𝑛 ) and off rate (𝑘𝑜𝑓𝑓 ). As mentioned in the method section we washed off the
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drug after reaching equilibrium and from these experiments we can extract the off rates. By
subtracting these off rates from the total rates, we can obtain the on rates.
When the flow is switched from Doxo flow in the experiments to that of the buffer, the buffer
will facilitate the unbinding of Doxo and flush the drug away. This will result in the length of the
DNA-Doxo complex to decrease from its equilibrium extension. The length decrease can be
characterized by an exponential decay equation shown below.
𝐿(𝑡) = (𝐿𝑒𝑞 − 𝐿0 )𝑒 −𝑘𝑜𝑓𝑓 𝑡 + 𝐿0

(7)

Where 𝐿𝑒𝑞 is the equilibrium extension at that particular for and concentration, 𝐿0 is the contour
length of DNA at that force in the absence of the drug and 𝑘𝑜𝑓𝑓 is the off rate. Figure 39 represent
an example of washing data (open circles) obtained washing away 27 nM Doxo at 20 pN constant
force and the exponential fit (solid line) that is used to obtain the off rate 𝑘𝑜𝑓𝑓 .
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Figure 39: Representative wash data obtained washing away the drug after reaching
equilibrium with 27 nM Doxo at 20 pN. The extension of DNA-Doxo (open circles) fitted
to equation (7) to obtain the off rate, 𝑘off.
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Once the 𝐾off value is obtained, the on rates 𝐾on can be extracted through the following
expression:
𝐾tot = 𝐾on + 𝐾off

(8)

Unfortunately, we are not done with completing the analysis of the washing experiments. This
analysis will be completed and included in the manuscript we are planning on writing.

Supplemental Experiments
The biggest question still out there is the extensions that we get during the release curves in the
stretch and release experiments showing similar values as constant force experiments. Does this
suggest that the melting somehow facilitates the binding of Doxo? If that is the case, can we still
characterize Doxo as a classical intercalator? To explore this fact our theoretical collaborator
suggested returning to the stretch and release experiments at a slower pace. The idea behind
this is to provide the drug enough time to reach equilibrium during each step of the process.
During the normal stretch and release the DNA is stretched with a 100 nm step size and after
each step a delay of 75 ms is given. This is to accommodate the time to collect 1000 data points
and average at each step. To facilitate Doxo binding to reach equilibrium at each step, this step
delay was increased to 60000 ms, hence calling it a delayed stretching experiment. These delayed
stretches would only go through the elastic regime because of the time it takes to conduct one
stretch and release experiment. Although we have done some preliminary experiments, we need
to do more data analysis and data acquisition to confirm any trend.
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Discussions
Doxo is one of the most prominently used cancer therapeutics yet the mechanism by which it
binds at the molecular level is left largely uncharacterized. One prominent way to prevent cancer
progression is halting DNA replication. In the study, which we have conducted over the past four
years we have investigated the way in which Doxo binds to the DNA at the single molecule level.
Based on Doxo’s structure and previous studies it is believed to behave as a classical intercalator
but our study challenges that notion with clear evidence. Doxo does not only need an extended
amount of time to bind to DNA but it also seems that the DNA melting also facilitates its binding.
One way to test whether melting is facilitating the equilibrium is to do delayed stretch
experiments as discussed in the results section. In these experiments after each 100 nm step we
take with the DNA we wait for almost a minute to provide enough time to reach equilibrium along
the stretch. We started these experiments but need more data to confirm what is happening.
The equilibrium DNA extension upon one intercalation event, ∆𝑥𝑒𝑞 = 0.40 ± 0.02 nm, is pretty
high compared to other classical intercalators studied. Other classical intercalators such as
Ethidium, and Oxazole Yellow (YO) have ∆𝑥𝑒𝑞 values of 0.25 ± 0.03 nm and 0.23 ± 0.01 nm
respectively56. On the other hand, the ∆𝑥𝑒𝑞 value for Doxo is comparable to the extensions
obtained with threading intercalators.

Threading intercalators such as Thiocoraline, and

(Δ,Δ - Pc)+4 have ∆𝑥𝑒𝑞 values of 0.41 ± 0.01 nm and 0.44 ± 0.04 nm respectively56. Exemplifying
the fact that, the length extension of many classical intercalators is much less than that of Doxo.
Our hypothesis from this is that Doxo could possibly be forming dimers before binding at the
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micromolar concentration as well, not only the millimolar range as previously described. Further,
the positively charged Doxo in solution could be interacting with the negatively charged
backbone of the DNA which leads to groove binding. This could create a two-state binding
mechanism of Doxo to DNA. The analysis that we have done is based upon single state binding.
If there are two states involved, we have to reconsider the fitting models and rethink on how
proceed further. This becomes a bigger challenge because there are no standards established yet
to analyze groove binders with optical tweezers. Although there are handful of studies that have
been done at low forces to characterize groove binding, it has not been completely characterized
through higher forces at the single molecule level.
Moving forward, the very first thing to do is to continue the preliminary data acquisition of the
delayed stretch experiments and see if it matches that of the constant force experiments. If it
does then we have characterized Doxo’s binding to the DNA at high forces for the first time,
obtaining binding kinetics and affinity. This would be the first study of such and furthermore of a
classical intercalator behaving as a threading intercalator.
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Appendix 1: Recognizing DNA as the Genetic Material
In 1859 a famous scientist by the name of Charles Darwin pitched a theory in one of the most
famous scientific pieces of all time, “The Origin of Species”59. Darwin was attempting to propose
his theory of natural selection, where a species will change in small ways causing a population to
change over several generations, otherwise known as evolution. He used an example in which he
stated that whales could be rendered from a bear if given ample conditions and time 59. With the
explanation being, black bears were known to catch insects by swimming with their mouths open
which could be related to whales, which are more aquatic in structure and habitat but carries out
a similar function in the water. He later removed this analogy in later editions of his book when
the scientific community did not respond the way in which he expected. It was concluded by
Darwin that organisms possess the ability to change overtime passing on both physical and
behavioral traits to following generations. This would be scrutinized by scientists for years to
come and the biggest question raised was: what causes the species to change over time?
Six years later, Gregor Mendel was studying pea and fuchsias plants in his botanical garden within
the capitol of Austria, Vienna, to understand the question posed from Darwin’s theory. Mendel’s
experiments60 with these plants went unrecognized for many years by others not utterly
understanding its significance. His work introduced the world to proteins, modern genetics, and
describe the principles of heredity61.
In 1869, a few hundred miles North into Germany at the Felix Hoppe-Seyler Laboratory
(figure A1)62, a Swiss doctor named Friedrich Miescher studied leukocytes (white blood cells). He
was trying to understand proteins and their functions through a chemical isolation experiment.
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During these experiments, he stumbled upon a novel substance that was neither that of a protein
or a lipid, what he called “nuclein”63.

Figure A1: The kitchen of the Tubingen castle where Miescher worked
on his discovery of DNA. This room formed part of the Hoppe-Seyler's
Lab. Photo was taken by Paul Sinner in 1879

For the years to come Miescher’s finding of nuclein (the mixture of nucleic acids and associated
proteins) was disregarded and null to the idea that it could hold genetic material. Scientists
believed it was far too simple to hold all the information of our genome thus proteins continued
to be the accepted genetic material. (Now scientist give credit to Miescher as the one who
discovered DNA). Between 1885 and 1901, Albrecht Kossel discovered that DNA composed of
four bases; adenine (A), cytosine (C), guanine (G), thymine (T) whose chemical structures can be
seen in figure 110.
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Phoebus Levene, who worked with Kossel continued to work on understanding the DNA
structure. He discovered that DNA is a long chain molecule that was made up of three
components; a phosphate, a pentose (five carbon) sugar named deoxyribose, and one of the four
nitrogenous bases (A, T, C, G). Levene stated that the bonding of the three groups would form
what is called a nucleotide64. But he incorrectly proposed the tetranucleotide structure, where 4
of these nucleotides form a small circular molecule, which then repeats to form the long chain
molecule. Based on the structure he proposed Levene believed that the DNA cannot be the
genetic material and sided with those who believed protein as the genetic material.
In 1928 Frederick Griffith would return to the notion of DNA being involved in inheritance.
Griffiths’ experiments in Liverpool investigated the way in which two strains of bacterium
affected the lives of mice65. To conclude the experiment in looking at the effect of the different
bacterium on the lives of the mice he introduced the theory of competence and a transformation
principal66. The community took this rather haphazardly not fully adopting it until 1944 when
Oswald Avery confirmed Griffiths’ hypothesis and research stating that this transforming
substance was the genetic material of the cell, or DNA67.
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Appendix 2: Polymer Models describing the dsDNA and ssDNA
The standard DNA stretching curve obtained while stretching dsDNA that is free to rotate is
believed to go through a phase transition around 65 pN (Figure A2). This transition is known as
force induced melting transition, where the dsDNA is converted into mostly ssDNA. The polymer
models, the Worm-Like Chain (WLC) model (green) that describes the dsDNA and the Freely
Jointed Chain (FJC) Model that describes ssDNA (blue) is also shown in the plot. These models
validates that the transition at 65 pN is the where dsDNA is converted into ssDNA.

Figure A2: DNA stretch (black solid) and release (black dashed) are shown

along with the worm-like chain model (green) that describes dsDNA and
freely jointed chain model (blue) that describes ssDNA
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Worm Like Chain Model
In 1994 it was shown that the force versus extension curve of a dsDNA molecule can be modeled
after the modified worm-like chain (WLC) model68, a polymer model that is used to describe semirigid polymers.
In regard to small pN forces, between that of 0.01 and 10pN, DNA will act as an entropic spring
where the WLC model can accurately describe the DNA by assuming smooth distribution of
bonding angles. The model describes the force (𝐹) observed within the DNA with particular
contour length 𝐿0 when the it is extended by an extension (𝑥):

𝐹𝑃
1
𝑥 −2 1 𝑥
= (1 − ) − +
𝑘B𝑇
4
𝐿0
4 𝐿0

Where the contour length broadly defines the length of the molecule when it is at the maximum
length without being stretched, 𝑘B is the Boltzmann constant, 𝑇 is the temperature and P is the
persistence length that describes the flexibility of the molecule.
As the DNA is stretched beyond its contour length under higher forces the approximate solution
for the extension can be mathematically represented as18:
1

1 𝐾b 𝑇 2 𝐹
) + ]
𝑥 = 𝐿0 [1 − (
2 𝐹𝑃
𝑆

Where S is the elastic stretching modulus accounting for how the backbone of the molecule
extends.
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Freely Jointed Chain Model
Double stranded DNA (dsDNA) has a more rigid structure than that of single stranded DNA
(ssDNA) due to the base pairing and stacking interactions within the molecule. This in turns makes
for a more rigid molecule overall in the dsDNA form compared to that of the ssDNA. Unlike that
of the WLC the Freely Jointed Chain Model (FJC) breaks down the molecule into individual parts,
monomers if you will, what can be connected freely through wide range of bond angles like
jointed chains.
An expression for the observable length of ssDNA under a force (𝐹); this can be written as18:
2𝑃𝑠𝑠 𝐹
1 𝑘B𝑇
𝐹
)− (
)] [1 + ]
𝑧 = 𝐿0.ss [coth (
𝑘B𝑇
2 𝑃𝑠𝑠 𝐹
𝑃𝑠𝑠

Where z represents the length of the ssDNA being stretched, 𝐿0,ss, and 𝑃𝑠𝑠 are the contour and
persistence lengths of ssDNA.
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Appendix 3: Constant Force Vs Stretch and Release
We did stretch and release of the DNA to different positions with respect to the melting transition
in the presence of 15 nM Doxo to understand whether the melting facilitates the binding.
Table 1: The average stretching length from these experiments at each point in the melting transition (MT) are compared with
that of the equilibrium extensions obtained from constant force measurements.

Force

Stretch and
Release Before
MT

Stretch and
Release up to
the Beginning
of MT

Stretch and
Release up to
the Midpoint
of MT

Stretch and
Release up to
the End of MT

Constant Force
Measurement

(pN)

(nm)

(nm)

(nm)

(nm)

(nm)

20

0.336 ± 0.003

0.351 ± 0.017

0.357 ± 0.014

0.350 ± 0.011

0.340 ± 0.001

30

0.342 ± 0.003

0.358 ± 0.018

0.367 ± 0.013

0.356 ± 0.013

0.349 ± 0.003

40

0.348 ± 0.003

0.365 ± 0.020

0.376 ± 0.013

0.362 ± 0.017

0.360 ± 0.004

50

0.357 ± 0.005

0.371 ± 0.021

0.384 ± 0.014

0.370 ± 0.013

0.375 ± 0.006

It is clear that stretch and release before reaching the melting transition (blue column) has the
lowest extension at every force indicating very little Doxo binding. But progressively stretching
into the transition (green and yellow column) increases the extension indicating more Doxo
binding at all four forces. But once you start stretching to the end of the transition (red column)
the extension shrinks back a little bit at all four forces.
The values obtained with stretch and release through the entire melting transition is similar to
the equilibrium extension value obtained in the constant force measurements (grey column)
within uncertainties at all four forces.
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Appendix 4: McGhee Von-Hippel Isotherm Model

In 1974 James McGhee and Peter Von-Hippel created the elegant analytical expression for the
isotherm describing how a ligand can bind to a lattice like structure. The McGhee Von-Hippel
(MGVH) Model used three parameters, (1) Intrinsic binding constant, K, (2) Unitless cooperative
parameter, w, and (3) number of lattice sites covered by a ligand, n to characterize number of
ligands bound per lattice site. Conditional probabilities were used to obtain the original McGhee
and Von Hippel formula:

𝑣
1 + (2𝑤 − 𝑛 − 1)𝑣 + 𝑄
2𝑤(1 − 𝑛𝑣)
= 𝐾𝑤(1 − 𝑛𝑣)
[
]
(2𝑤 − 1)(1 − 𝑛𝑣) + 𝑣 + 𝑄 (2𝑤 − 1)(1 − 𝑛𝑣) + 𝑣 + 𝑄
𝐿

Where, 𝑄 = √(1 − (𝑛 + 1)𝑣 2 ) + 4𝑤𝑣(1 − 𝑛𝑣)

Furthermore, 𝑣 is the number of bound ligands per lattice site holding a value between 0 and
1/n.
For the experiments in which we conduct we use the MGVH isotherm to determine a small
molecule’s binding affinity at a certain force to DNA which can be thought of as a onedimensional lattice structure. More simply stated the molecule’s binding affinity just means its
strength of binding between the ligand (Doxo) and a receptor (DNA), where in parentheses
regards our specific experiment.
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In particularly we are focused with the one-dimensional homogeneous lattice of DNA, meaning
that non-specific binding of the ligand into the bases of the DNA, which reduces the equation to
a simpler form20:

𝜃(𝐾d, 𝑛) =

𝐶
𝑛(1 − 𝜃)𝑛
𝐾d (1 − 𝜃 + 𝜃 )𝑛−1
𝑛

Where 𝐾d is the dissociation constant, C is the concentration, 𝜃 is the fractional equilibrium
binding, and n is the binding site size.
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